Glenmede Trust’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,297
| Closed | -$279K | – | 1438 |
|
|
2024
Q4 | $279K | Sell |
2,297
-41
| -2% | -$4.99K | ﹤0.01% | 1124 |
|
|
2024
Q3 | $292K | Buy |
2,338
+47
| +2% | +$5.87K | ﹤0.01% | 1099 |
|
|
2024
Q2 | $362K | Sell |
2,291
-342
| -13% | -$54K | ﹤0.01% | 1001 |
|
|
2024
Q1 | $341K | Buy |
2,633
+226
| +9% | +$29.3K | ﹤0.01% | 1021 |
|
|
2023
Q4 | $232K | Buy |
2,407
+93
| +4% | +$8.97K | ﹤0.01% | 1106 |
|
|
2023
Q3 | $281K | Buy |
2,314
+77
| +3% | +$9.33K | ﹤0.01% | 1017 |
|
|
2023
Q2 | $308K | Hold |
2,237
| – | – | ﹤0.01% | 983 |
|
|
2023
Q1 | $308K | Sell |
2,237
-4
| -0.2% | -$551 | ﹤0.01% | 988 |
|
|
2022
Q4 | $290K | Buy |
2,241
+33
| +1% | +$4.28K | ﹤0.01% | 995 |
|
|
2022
Q3 | $243K | Buy |
+2,208
| New | +$243K | ﹤0.01% | 1030 |
|
|
2021
Q1 | – | Sell |
-2,022
| Closed | -$343K | – | 1248 |
|
|
2020
Q4 | $343K | Sell |
2,022
-104
| -5% | -$17.6K | ﹤0.01% | 934 |
|
|
2020
Q3 | $297K | Sell |
2,126
-2
| -0.1% | -$279 | ﹤0.01% | 924 |
|
|
2020
Q2 | $340K | Buy |
2,128
+19
| +0.9% | +$3.04K | ﹤0.01% | 867 |
|
|
2020
Q1 | $272K | Hold |
2,109
| – | – | ﹤0.01% | 1083 |
|
|
2019
Q4 | $272K | Hold |
2,109
| – | – | ﹤0.01% | 1083 |
|
|
2019
Q3 | $158 | Sell |
2,109
-4
| -0.2% | – | ﹤0.01% | 1255 |
|
|
2019
Q2 | $320 | Hold |
2,113
| – | – | ﹤0.01% | 1027 |
|
|
2019
Q1 | $251 | Buy |
2,113
+100
| +5% | +$12 | ﹤0.01% | 1098 |
|
|
2018
Q4 | $219 | Buy |
2,013
+13
| +0.7% | +$1 | ﹤0.01% | 1086 |
|
|
2018
Q3 | $323K | Hold |
2,000
| – | – | ﹤0.01% | 1002 |
|
|
2018
Q2 | $264K | Sell |
2,000
-300
| -13% | -$39.6K | ﹤0.01% | 985 |
|
|
2018
Q1 | $127K | Hold |
2,300
| – | – | ﹤0.01% | 1319 |
|
|
2017
Q4 | $127K | Buy |
2,300
+300
| +15% | +$16.6K | ﹤0.01% | 1319 |
|
|
2017
Q3 | $90K | Hold |
2,000
| – | – | ﹤0.01% | 1451 |
|
|
2017
Q2 | $59K | Hold |
2,000
| – | – | ﹤0.01% | 1541 |
|
|
2017
Q1 | $59K | Hold |
2,000
| – | – | ﹤0.01% | 1541 |
|
|
2016
Q4 | $54K | Sell |
2,000
-38
| -2% | -$1.03K | ﹤0.01% | 1583 |
|
|
2016
Q3 | $124K | Buy |
2,038
+38
| +2% | +$2.31K | ﹤0.01% | 1340 |
|
|
2016
Q2 | $38K | Hold |
2,000
| – | – | ﹤0.01% | 1670 |
|
|
2016
Q1 | $39K | Hold |
2,000
| – | – | ﹤0.01% | 1603 |
|
|
2015
Q4 | $77K | Hold |
2,000
| – | – | ﹤0.01% | 1434 |
|
|
2015
Q3 | $64K | Hold |
2,000
| – | – | ﹤0.01% | 1504 |
|
|
2015
Q2 | $60K | Sell |
2,000
-5,000
| -71% | -$150K | ﹤0.01% | 1571 |
|
|
2015
Q1 | $92K | Hold |
7,000
| – | – | ﹤0.01% | 1490 |
|
|
2014
Q4 | $101K | Buy |
7,000
+1,200
| +21% | +$17.3K | ﹤0.01% | 1528 |
|
|
2014
Q3 | $122K | Hold |
5,800
| – | – | ﹤0.01% | 1373 |
|
|
2014
Q2 | $172K | Hold |
5,800
| – | – | ﹤0.01% | 1224 |
|
|
2014
Q1 | $139K | Hold |
5,800
| – | – | ﹤0.01% | 1304 |
|
|
2013
Q4 | $118K | Buy |
5,800
+565
| +11% | +$11.5K | ﹤0.01% | 1344 |
|
|
2013
Q3 | $247K | Buy |
5,235
+235
| +5% | +$11.1K | ﹤0.01% | 1053 |
|
|
2013
Q2 | $190K | Buy |
+5,000
| New | +$190K | ﹤0.01% | 1096 |
|